Tuesday, April 19, 2016

BRIEF-Abivax gets clearance in Spain for second phase IIa trial in HIV/AIDS patients

* Abivax obtains regulatory and ethics clearance in Spain to

begin second phase iia clinical trial for ABX464 in HIV/AIDS

patients

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)